Actively Recruiting
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Led by Peking Union Medical College Hospital · Updated on 2026-01-06
3000
Participants Needed
10
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multi-center observational study.The start time for data collection is May 1, 2024. Patients' baseline and treatment data will be collected under informed concent. The purpose of this case registry study was to evaluate the safety and efficacy of irinotecan hydrochloride liposome injection II based therapy in Chinese patients with pancreatic cancer in the real world by collecting, understanding, and analyzing the etiology, clinical features, treatment pattern, treatment outcomes, and pharmacoeconomics changes in pancreatic cancer patients receiving this regimen.
CONDITIONS
Official Title
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with pancreatic ductal adenocarcinoma diagnosed by pathology or imaging
- Age 18 years or older, male or female
- Patients receiving treatment based on irinotecan hydrochloride liposome injection II
- Subjects voluntarily joined the study and signed the informed consent
You will not qualify if you...
- Confirmed pregnant or lactating women
- Researchers determined other conditions made the subject unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Actively Recruiting
2
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
3
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Actively Recruiting
4
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Actively Recruiting
5
Peking Unicersity First Hospital
Beijing, China
Actively Recruiting
6
Henan Provincial People's Hospital
Henan, China
Actively Recruiting
7
Ningbo Medical Center Lihuili Hospital
Ningbo, China
Actively Recruiting
8
Fudan University Shanghai Cancer Center
Shanghai, China
Actively Recruiting
9
Renji，Hospital
Shanghai, China
Actively Recruiting
10
Wuhan Union Hospital of China
Wuhan, China
Actively Recruiting
Research Team
T
Taiping Zhang, doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here